Original Research

Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens

Comstock TL, Morris TW, Gearinger LS, DeCory HH

Clinical Optometry 2014, 6:25-35

Published Date: 1 April 2014